Clinical Trial Update: To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Clinical trial NCT02974426, a Phase 3 study evaluating the timing of postoperative radiotherapy in stage IIIA (N2) non-small cell lung cancer, has been terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Non-small Cell Lung Cancer Stage IIIA, Radiotherapy | Phase 3 | Status: TERMINATED